Navigation Links
Physics strategy tested as solution for antibiotic resistance
Date:4/21/2010

tics cued to protein fluctuations in persister cells. Their finding that resonant activation fluctuating antibiotic treatments accelerates bacteria colony sterilization was published in the journal Physical Biology in March 2010 ("Resonant activation: a strategy against bacterial persistence," Fu, Zhu, and Xing. http://iopscience.iop.org/1478-3975/7/1/016013).

Xing acknowledges that that the computer simulation simplified the problem by neglecting further complication due to mutation, but said he believes the concept has applications for cancer treatment. "On and off dosing with chemicals could be as effective as or more effective than long-term dosage. You need to stop and let the body recover, then resume," he said.

He is particularly interested in conducting experiments to see if resonant activation could increase the efficiency of inducing a normal (somatic) cell into an undifferentiated or stem cell.

"Bacteria mutate quickly, but there could be applications for cancer or stem cell conversion, where mutation is slower or not an issue," Xing said.


'/>"/>

Contact: Susan Trulove
strulove@vt.edu
540-231-5646
Virginia Tech
Source:Eurekalert

Page: 1 2

Related biology news :

1. CCNY symposium April 23 to explore future of physics
2. Physics press conferences at next weeks American Physical Society March Meeting
3. The 43rd Midyear Meeting of the Health Physics Society
4. Health Physics Society recommends considering action for indoor radon below current guidelines
5. Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group
6. UTSA Physics Department receives $2.7 million to study nanomaterials
7. Nanophysics: Serving up Buckyballs on a silver platter
8. Cheap and efficient white light LEDs new design described in AIPs Journal of Applied Physics
9. American Institute of Physics announces awards for best science writing
10. Physics, math provide clues to unraveling cancer
11. 42nd Mid-year Topical Meeting of the Health Physics Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, North Carolina , ... in sein 35. Jahr als spezialisiertes Logistikunternehmen ... seine Position als einzige klinische Logistikfirma (Clinical ... soll. Die Kernbotschaft der neuen Kampagne lautet ... Protokollen und Lieferungen. Foto: ...
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
... revealed how the inhaled form of anthrax paralyzes the ... site of infection. , Anthrax killed five people in ... through the mail. The UF findings, published last week ... for anthrax victims. , The disease causes flu-like ...
... Tropical plants may be more adaptable than commonly thought to ... research shows. , A University of Florida scientist and other ... to acclimate to big changes in rainfall in at least ... rely on one form of the vital nutrient nitrogen in ...
... land area and number of species crystallized into a ... thought of as biological destinations where species from large ... in geographic seclusion. , Since islands have many ... logical that continents were rich sources from which islands ...
Cached Biology News:Anthrax paralyzes immune cells with lethal toxin, UF research shows 2Anthrax paralyzes immune cells with lethal toxin, UF research shows 3Scientists: As rainfall changes, tropical plants may acclimate 2Invasion of the island bats 2
(Date:3/5/2015)... NC (PRWEB) March 05, 2015 ... that Pierre Noel, M.D., Professor of Medicine, Mayo ... the Company’s Board of Directors. , ... are extremely fortunate to have Dr. Noel, a ... leading healthcare organization, join Entegrion’s Board. His expertise ...
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) ... Outlook 2015: New Therapy Ventures Pave the Way for ... All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen ... given a positive return and hence increased the interest ... select therapy/niche indication where the high treatment cost justifies ...
(Date:3/5/2015)... Thornton Cleveleys (UK) (PRWEB) March 05, 2015 ... Enhanced implantable polymer have received the CE mark (European) ... within the European Free Trade Association (EFTA) and the ... CE mark has now been granted to implants supplied ... degenerative disc spinal conditions. , Osimplant's Cervical Expandable ...
(Date:3/4/2015)... 2015 In an article published and posted ... Health Security review the clinical aspects of diseases caused ... bioweapons. The article, "Clinical Management of Potential Bioterrorism-Related Conditions," ... of the New England Journal of Medicine . ... , and Tom Inglesby—review the clinical management of conditions ...
Breaking Biology Technology:Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2
... risk of variant Creutzfeldt-Jakob Disease from plasma product completed ... - Scale-up phase ... to supply prion removal affinity ... CAMBRIDGE, United Kingdom, Jan. 23 /PRNewswire-FirstCall/,- ProMetic Life Sciences Inc. ...
... Institute and Rice University have created the darkest material ... thin coating comprised of low-density arrays of loosely vertically-aligned ... and one day could be used to boost the ... and other devices. The researchers who developed the material ...
... VANCOUVER, Jan. 22 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI ... host a conference call discussing its,financial results for the fourth quarter ... Thursday, February 14, 2008 at 11:00 AM ET ... Central), Dial information is as follows: ...
Cached Biology Technology:ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use 2ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use 3ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use 4ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use 5Researchers develop darkest manmade material 2Researchers develop darkest manmade material 3Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast 2
SHEEP ANTI FLECAINIDE...
... in refrigerators, freezers, or liquid nitrogen. Conveniently sized to ... color coding to project, user, lab, etc. Holes in ... air circulation. Supplied with 9 x 9 (12.7 mm ... dimensions: 13 x 13 x 5.1 cm H (5 ...
Recombinant Rhesus Monkey IFN-Alpha...
Homo sapiens HCLS1 associated protein X-1 Antigen: Recombinant Protein...
Biology Products: